Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.

Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.

[This corrects the article DOI: 10.1371/journal.pone.0229145.].

Bibliographic Details
Main Authors:	Anne-Caroline Jeannin, Joe-Elie Salem, Ziad Massy, Carole Elodie Aubert, Cees Vemeer, Chloé Amouyal, Franck Phan, Marine Halbron, Christian Funck-Brentano, Agnès Hartemann, Olivier Bourron
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0232996

Similar Items

Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.
by: Anne-Caroline Jeannin, et al.
Published: (2020-01-01)

Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy
by: Carole E. Aubert, et al.
Published: (2019-04-01)

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study
by: Olivier Bourron, et al.
Published: (2020-09-01)

Impaired hypoxic ventilatory drive induced by diabetic autonomic neuropathy, a cause of misdiagnosed severe cardiac events: brief report of two cases
by: Louis Schubert, et al.
Published: (2021-03-01)

Correction: Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.
by: PLOS ONE Staff
Published: (2021-01-01)

Renal Resistive Index Is Associated With Inactive Matrix Gla (γ‐Carboxyglutamate) Protein in an Adult Population‐Based Study
by: David A. Jaques, et al.
Published: (2019-09-01)

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis
by: Mathilde Sollier, et al.
Published: (2019-01-01)

Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma
by: Atanur Ersayin, et al.
Published: (2017-12-01)

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
by: Damien Denimal, et al.
Published: (2024-02-01)

Evolution of Matrix Gla and Bone Gla Protein Genes in Jawed Vertebrates
by: Nicolas Leurs, et al.
Published: (2021-03-01)

Inactive Matrix Gla Protein in Relation to Renal and Cardiac Functions and Cardiac Valvular Calcification Among Type 2 Diabetes Patients
by: Sara Reda, et al.
Published: (2023-10-01)

Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease
by: Christine R. Kaneski, et al.
Published: (2022-12-01)

3.2 INACTIVE MATRIX GLA PROTEIN IS CAUSALLY RELATED TO HEALTH OUTCOMES: A MENDELIAN RANDOMIZATION STUDY IN A FLEMISH POPULATION
by: Y.-P. Liu, et al.
Published: (2014-11-01)

Association of N-Acetyl Asparagine with QTc in Diabetes: A Metabolomics Study
by: Giacomo Gravina, et al.
Published: (2022-08-01)

The Expression of miR-155-5p and Local Matrix Gla Protein in Meningiomas
by: Gheorghe Simona Roxana, et al.
Published: (2021-07-01)

Otkriće Orhomena i obližnje citadele Gla
by: Helena Tomas
Published: (2011-01-01)

Nanoencapsulation as a novel delivery approach for therapeutic applications of gla-rich protein (GRP)
by: Nuna Araújo, et al.
Published: (2021-04-01)

5.4 MATRIX GLA PROTEIN IN RELATION TO LEFT VENTRICULAR DIASTOLIC FUNCTION
by: Thibault Petit*, et al.
Published: (2015-11-01)

Cardiac manifestations of Fabry disease in G3Stg/GlaKO and GlaKO mouse models-Translation to Fabry disease patients.
by: Abirami Kugadas, et al.
Published: (2024-01-01)

Fat fabulous fat : gamma linolenic acid (GLA) /
by: 309102 Miller, Bruce
Published: (1996)

Phenotypes of undiagnosed adults with actionable OTC and GLA variants
by: Jessica I. Gold, et al.
Published: (2023-10-01)

Research on discharge characteristics of GLA with surface pollution/icing
by: Pengkang Xie, et al.
Published: (2022-08-01)

P031: Fabry disease: Genotype/phenotype correlations for 17 novel GLA mutations by GLA activity and plasma Lyso-Gb3 levels
by: Neal Cody, et al.
Published: (2023-01-01)

Central Hemodynamics in Relation to Circulating Desphospho‐Uncarboxylated Matrix Gla Protein: A Population Study
by: Fang‐Fei Wei, et al.
Published: (2019-04-01)

Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction.
by: Fang-Fei Wei, et al.
Published: (2018-01-01)

Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts.
by: Johan M Lorenzen, et al.
Published: (2012-01-01)

The feasibility of implementing an English language version of GLA:D Back
by: J. Lemieux, et al.
Published: (2021-02-01)

GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza.
by: Christopher H Clegg, et al.
Published: (2014-01-01)

Evaluation of direct cost in case of insulin GLA-100rgine-100 switching to insulin GLA-100rgine-300 in diabetes mellitus in real clinical practice
by: D. Yu. Belousov, et al.
Published: (2018-05-01)

Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
by: Paul Y Boxma, et al.
Published: (2012-01-01)

Extra-cranial radiotherapy in anti-PD-1-treated melanoma patients: A systematic review
by: Philippe Saiag, et al.
Published: (2024-12-01)

Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease
by: Ilona Kurnatowska, et al.
Published: (2016-04-01)

Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases.
by: Carla S B Viegas, et al.
Published: (2017-01-01)

P4.4 INHIBITION OF ARTERIAL CALCIFICATION BY MATRIX GLA PROTEIN AS DETERMINANT OF RENAL FUNCTION IN THE GENERAL POPULATION
by: Fangfei Wei*, et al.
Published: (2015-11-01)

Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?
by: Chloé Amouyal, et al.
Published: (2016-01-01)

The bone Gla protein osteocalcin is expressed in cranial neural crest cells
by: Rotem Kalev-Altman, et al.
Published: (2024-11-01)

Novel GLA Deletion in a Cypriot Female Presenting with Cornea Verticillata
by: Theodoros Georgiou, et al.
Published: (2016-01-01)

Matrix Gla Protein drives stemness and tumor initiation in ovarian cancer
by: V. Nieddu, et al.
Published: (2023-03-01)

The role of Matrix Gla Protein in ossification and recovery of the avian growth plate
by: Harel eDan, et al.
Published: (2012-07-01)

Matrix Gla protein regulates adipogenesis and is serum marker of visceral adiposity
by: Chaomin Li, et al.
Published: (2020-01-01)